[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368656-105":59,"doc-detail-368656-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","early-neoplastic-lesions-of-the-pancreas-initiation-progression-and-opportunities-for-precancer-interception","Early neoplastic lesions of the pancreas - initiation, progression, and opportunities for precancer interception","","Early neoplastic lesions of the pancreas, particularly pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN), are key precursor pathways to pancreatic ductal adenocarcinoma. Despite clear biological drivers, practical precancer interception is constrained by limited detection, inadequate risk stratification, and interventions that can cause substantial morbidity. Advances in liquid biopsy, spatial multiomics, and machine learning are used to map molecular landscapes of precursor development and progression. The review summarizes histologic phenotypes, clinical features, and intrinsic and extrinsic drivers, emphasizing current and future interception opportunities.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/early-neoplastic-lesions-of-the-pancreas-initiation-progression-and-opportunities-for-precancer-interception/368656/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/early-neoplastic-lesions-of-the-pancreas-initiation-progression-and-opportunities-for-precancer-interception/368656.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is precursor-stage interception important in pancreatic ductal adenocarcinoma (PDAC)?","Question",{"text":112,"@type":113},"PDAC has poor survival even when localized, and metastatic capability is thought to arise relatively early. Therefore, clinically impactful interception should ideally occur before invasive disease develops at the precursor stage.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are PanIN and IPMN, and how are they related to PDAC?",{"text":117,"@type":113},"PDAC is described as progressing from two main precursor lesions: pancreatic intraepithelial neoplasia (PanIN) or intraductal papillary mucinous neoplasm (IPMN). The review focuses on their histologic phenotypes, clinical characteristics, and molecular drivers.",{"name":119,"@type":110,"acceptedAnswer":120},"What major obstacles limit pancreatic precancer interception strategies?",{"text":121,"@type":113},"Key barriers include difficulties in detecting precursor lesions (especially microscopic PanIN), challenges with risk stratification, and low-morbidity intervention. Researchers also face limitations in studying PanIN progression because it can be examined mainly at fixed time points after resection.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368656,1790197915,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","The Journal of Clinical Investigation REVIEW SERIES: PANCREATIC CANCER  \nSeries Editor: Ben Z. Stanger  \nEarly neoplastic lesions of the pancreas: initiation, progression, and opportunities for precancer interception  \nBrian A. Pedro1 and Laura D. Wood1,2  \n1Department of Pathology, and 2Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.  \nPancreatic ductal adenocarcinoma (PDAC) is known to progress from one of two main precursor lesions: pancreatic intraepithelial neoplasia (PanIN) or intraductal papillary mucinous neoplasm (IPMN). The poor survival rates for patients with PDAC, even those diagnosed with localized disease, highlight the need for pancreatic cancer interception at the precursor stage. Although their basic biological drivers are well characterized, practical strategies for PanIN and IPMN interception remain elusive due to difficulties with detection, risk stratification, and low-morbidity intervention. Recently, advancesin liquid biopsy, spatial multiomics analysis, and machine learning technology have provided deeper understanding of the molecular landscapes underlying pancreatic precursor development and progression. In this Review, we outline the different histologic phenotypes, clinical characteristics, and neoplastic cell–intrinsic and –extrinsic drivers of PanINs and IPMNs, with particular focus on current and potential future opportunities for pancreatic precancer interception.  \nIntroduction  \nPancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a dismal overall prognosis (1, 2) . The sobering statistics regarding PDAC survival, even for those with early-stage disease, highlight the crucial importance of early PDAC interception. Speaking broadly, cancer interception aims to identify and halt the progression of cancer before the disease can affect patient survival (3) . For some cancer types, such as many breast, thyroid, or prostate carcinomas, interception of localized disease through surgical resection and/or targeted therapy is sufficient to mitigate any significant impact on long-term survival (4) . By contrast, metastatic capability is believed to arise relatively early during PDAC progression, and PDAC therefore carries significant risk even to patients with localized disease, with five-year survival of only 44%(4, 5) . Thus, clinically impactful PDAC interception strategies would ideally be carried out at the precursor stage, before the development of invasive disease.  \nThe vast majority of PDACs progress from one of two major types of precursor lesions — pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN)  \n— yet viable approaches for pancreatic precancer interception remain largely elusive. For example, while IPMNs are radiologically detectable, most PDACs are believed to arise from PanINs that are microscopic by definition (6, 7) and are at this time only identifiable within formalin-fixed, paraffin-embedded tissue sections. This microscopic nature of PanINs presents multiple challenges in PDAC diagnosis and research. Firstly, even in high-risk patients undergoing screening via endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI), most PanINs (whether low-  \nConflict of interest: The authors have declared that no conflict of interest exists. Copyright: © 2025, Pedro et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nReference information: J Clin Invest. 2025;135(14):e191937.  \n[https://doi.org/10.1172/JCI191937](https://doi.org/10.1172/JCI191937).  \nor high-grade) are essentially undetectable by imaging. Secondly, researchers’ ability to track and characterize the natural progression of human PanINs is limited, as they can typically only be studied at fixed time points after resection. Additionally, while low-grade pancreatic precancers are highly prevalent (8, 9), the location and anatomic properties o","cbCailJaCpC8Mtmk","https://ap.wps.com/l/cbCailJaCpC8Mtmk","pdf",4990100,"English","# Introduction\n## Pancreatic ductal adenocarcinoma and the rationale for precursor-stage interception\n## Precursor lesions: PanIN and IPMN\n### Detection challenges for microscopic PanIN\n### Tracking natural progression and identifying high-risk lesions\n## Molecular drivers and remaining knowledge gaps\n# PanIN — histology and molecular characteristics","[{\"question\":\"Why is precursor-stage interception important in pancreatic ductal adenocarcinoma (PDAC)?\",\"answer\":\"PDAC has poor survival even when localized, and metastatic capability is thought to arise relatively early. Therefore, clinically impactful interception should ideally occur before invasive disease develops at the precursor stage.\"},{\"question\":\"What are PanIN and IPMN, and how are they related to PDAC?\",\"answer\":\"PDAC is described as progressing from two main precursor lesions: pancreatic intraepithelial neoplasia (PanIN) or intraductal papillary mucinous neoplasm (IPMN). The review focuses on their histologic phenotypes, clinical characteristics, and molecular drivers.\"},{\"question\":\"What major obstacles limit pancreatic precancer interception strategies?\",\"answer\":\"Key barriers include difficulties in detecting precursor lesions (especially microscopic PanIN), challenges with risk stratification, and low-morbidity intervention. Researchers also face limitations in studying PanIN progression because it can be examined mainly at fixed time points after resection.\"}]","Early neoplastic lesions of the pancreas - initiation, progression, and opportunities for precancer interception | PDF",1790177879,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e934863a54aac0e8a1eeba866a7b7d95.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31eb70ca368983ece9bc339b7d4dee97.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da69a5b9ba3b355f1086db1e6c05c2c8.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/839c46e710e0c3d07059a6b060a25ac5.webp",980,1311]